Phase I study of paclitaxel and day 1/day 8 gemcitabine in patients with solid malignancies. [electronic resource]
Producer: 20000921Description: 349-52 p. digitalISSN:- 0277-3732
- Adult
- Aged
- Antimetabolites, Antineoplastic -- administration & dosage
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Colonic Neoplasms -- drug therapy
- Deoxycytidine -- administration & dosage
- Diarrhea -- chemically induced
- Esophageal Neoplasms -- drug therapy
- Exanthema -- chemically induced
- Female
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Nausea -- chemically induced
- Neoplasm Staging
- Neoplasms, Unknown Primary -- drug therapy
- Neutropenia -- chemically induced
- Paclitaxel -- administration & dosage
- Pancreatic Neoplasms -- drug therapy
- Paresthesia -- chemically induced
- Urinary Bladder Neoplasms -- drug therapy
- Vomiting -- chemically induced
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.